Press Releases

81_IGC-Pharma-Expands-Phase-2-CALMA-Trial-with-New-Clinical-Trail-Site-at-Integrative-Clinical-Trials-in-New-York_
IGC Pharma Expands Phase 2 CALMA Trial with New Clinical Trail Site at Integrative Clinical Trials in New York 
Read More →
80_IGC-Pharma-Expands-Phase-2-CALMA-Trial-with-New-Clinical-Site-at-Dominion-Medical
IGC Pharma Expands Phase 2 CALMA Trial with New Clinical Site at Dominion Medical Associates, a Lightship network site, in Richmond, Virginia 
Read More →
79_IGC-Pharma-Aligns-Fiscal-Year-with-Calendar-Year-to-Enhance-U.S.-Investor-Comparability
IGC Pharma Aligns Fiscal Year with Calendar Year to Enhance U.S. Investor Transparency and Comparability 
Read More →
78_IGC-Pharma-Raises-Capital-to-Advance-IGC-AD1-Phase-2-Trial-and-AI-Platform
IGC Pharma Raises Capital to Advance IGC-AD1 Phase 2 Trial 
Read More →